Re-imagine clinical research with objective digital assessments

Drive Pharma to uncover real-world data and evidence from pre-clinical to commercialization by measuring patients symptoms through their smartphones

Top 10 Global Pharma Companies are transforming their R&D with Beats Medical

We deploy a white-labeled or co-branded digital platform that integrates into your clinical pipeline, delivering objective assessments to enhance your R&D activities from pre-clinical to commercialization, or even to provide tailored digital therapies that drive patients’ behavioral changes.

Our cross-disease, multi-symptom platform technology, Colbolt©, requires no additional hardware and provides the broadest reach on the market across iOS and Android devices to capture high-quality data.

Read more about what Colbolt© can provide here.

Re-imagine
clinical research

Simply translate your needs from pre-clinical to commercialization into a configurable digital platform, with a team of clinical and digital experts. Defining your digital strategy for clinical research shouldn’t be hard.

Re-imagine
Drug Development

Utilize digital assessments supported by AI to rapidly learn about specific diseases, without managing logistics or distributing hardware to patients. Uncover the right endpoints for your clinical trial.

Re-imagine
Drug Development

Move from any clinical trial phase to drug approval with the support of digital assessments that will accelerate your progress toward better clinical outcomes. Learn faster, make the right decisions about your assets.

Smartphone-based assessments
adaptable to
every trial

Cross-disease and
Multi-symptom

Provide objective measures of mobility, fine motor, and speech alongside eCOAs/PROMs

Bring your own device (BYOD)

Recruit patients regardless of their devices or geography without additional wearables or sensors

x5 increase in
data precision

Use standardized digital assessments with a 5-fold increase compared to traditional methods

Embedded digital biomarkers approach

Explore measures that can pave the way as digital biomarkers for particular conditions

Our
Partners

We are proud to work with industry leading partners to better understand, engage and treat patients with CNS and rare conditions.

Our aim is to generate better outcomes for all by partnering for scale. Our partnerships deliver win – wins for our clients with a low barrier to entry and a high percentage of success.

Trusted by

97 million

steps taken by our users around the world

30+ countries

where our solution is commercialised

11 years

leading the field of digital clinical research

    Contact Us